Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA LP et al v. APOTEX, INC. et al
Case Number:
1:09-cv-01518
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 20, 2009
Apotex Enjoined From Launching Generic Pulmicort
AstraZeneca Pharmaceuticals LP has been granted a preliminary injunction in its suit to prevent Apotex Inc. from launching a generic version of children's asthma treatment Pulmicort Respules, a month after a judge issued a temporary restraining order against Apotex.
-
April 16, 2009
Apotex Can't Launch Generic Pulmicort Yet: Judge
A federal court has temporarily blocked Apotex Inc. from launching a generic version of Pulmicort Respules, AstraZeneca Pharmaceuticals LP’s successful asthma treatment for children.